Latest filing published 11 Jun 2010 for Fennec Pharmaceuticals INC..
Insider track record
No signal scores available.
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -23.3%Entry US$11.50 · Close at T+365 US$8.82
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert W. Butts: trading record in brief
Robert W. Butts has filed trades across 2 companies (mainly through SEC (Form 4)), most often in IES Holdings, Inc. and Fennec Pharmaceuticals Inc. Between 3 January 2007 and 8 June 2010, the trades on record add up to 4 filings.
No open-market sale appears; the market trades are 4 purchases worth €1.2M. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2010: 1 purchase and no sales on the market.
Half of the purchases are above €387k and half below. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +12.1%. They describe history only and say nothing certain about the share price ahead.
Most recently, on 11 June 2010, the filings show an open-market purchase in Fennec Pharmaceuticals Inc. Typically, a trade is published a median of 6 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert W. Butts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 0Common SharesSEC:0001144204-10-033206:0Canonical exit: 6 Sept 2010 (T+90)
- 28,300 shares@ US$18.00Common StockSEC:0001329587-07-000012:0Canonical exit: 3 Apr 2007 (T+90)
- 12,300 shares@ US$18.2516Common StockSEC:0001329587-07-000012:1Canonical exit: 5 Apr 2007 (T+90)
- 46,600 shares@ US$18.9942Common StockSEC:0001329587-07-000012:2Canonical exit: 8 Apr 2007 (T+90)
4 of 4 declarations
